Attended 2025 BIOSeedin Conference (5/15-16/2025)
Attended 2024 SAPA Annual Conference
(9/27-28/2024)
Series B financing completed
(3/20/2023)
Attended J.P. Morgan Healthcare Conference (1/17/2025)
Roadshow on Antibody China 2025
(2/27-28/2025)
LB1410 in combination with LB4330 Phase I/II NMPA approval
(3/11/2024)
Attended BIO US 2025 Conference
(6/16-19/2025)